Literature DB >> 16085913

Lipoprotein-dependent and -independent immune responses to spirochetal infection.

Juan C Salazar1, Constance D Pope, Meagan W Moore, Jonathan Pope, Thomas G Kiely, Justin D Radolf.   

Abstract

In this study, we used the epidermal suction blister technique, in conjunction with multiparameter flow cytometry, to analyze the cellular and cytokine responses elicited by intradermal injection of human volunteers with synthetic analogs for spirochetal lipoproteins and compared the responses to findings previously reported from patients with erythema migrans (EM). Compared with peripheral blood (PB), lipopeptides derived from the N termini of the Borrelia burgdorferi outer surface protein C and the 17-kDa lipoprotein of Treponema pallidum (OspC-L and 17-L, respectively) elicited infiltrates enriched in monocytes/macrophages and dendritic cells (DCs) but also containing substantial percentages of neutrophils and T cells. Monocytoid (CD11c(+)) and plasmacytoid (CD11c(-)) DCs were selectively recruited to the skin in ratios similar to those in PB, but only the former expressed the activation/maturation surface markers CD80, CD83, and DC-SIGN. Monocytes/macrophages and monocytoid DCs, but not plasmacytoid DCs, displayed significant increases in surface expression of Toll-like receptor 1 (TLR1), TLR2, and TLR4. Staining for CD45RO and CD27 revealed that lipopeptides preferentially recruited antigen-experienced T-cell subsets; despite their lack of antigenicity, these agonists induced marked T-cell activation, as evidenced by surface expression of CD69, CD25, and CD71. Lipopeptides also induced significant increases in interleukin 12 (IL-12), IL-10, gamma interferon, and most notably IL-6 without corresponding increases in serum levels of these cytokines. Although lipopeptides and EM lesional infiltrates shared many similarities, differences were noted in a number of immunologic parameters. These studies have provided in situ evidence for a prominent "lipoprotein effect" during human infection while at the same time helping to pinpoint aspects of the cutaneous response that are uniquely driven by spirochetal pathogens.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085913      PMCID: PMC1182186          DOI: 10.1128/CDLI.12.8.949-958.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  85 in total

1.  Immunogenic integral membrane proteins of Borrelia burgdorferi are lipoproteins.

Authors:  M E Brandt; B S Riley; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

2.  Major integral membrane protein immunogens of Treponema pallidum are proteolipids.

Authors:  N R Chamberlain; M E Brandt; A L Erwin; J D Radolf; M V Norgard
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

3.  Regulation of CD27 expression on subsets of mature T-lymphocytes.

Authors:  R Q Hintzen; R de Jong; S M Lens; M Brouwer; P Baars; R A van Lier
Journal:  J Immunol       Date:  1993-09-01       Impact factor: 5.422

4.  Borrelia burgdorferi outer surface lipoproteins OspA and OspB possess B-cell mitogenic and cytokine-stimulatory properties.

Authors:  Y Ma; J J Weis
Journal:  Infect Immun       Date:  1993-09       Impact factor: 3.441

5.  MyD88 plays a unique role in host defense but not arthritis development in Lyme disease.

Authors:  Devin D Bolz; Rhianna S Sundsbak; Ying Ma; Shizuo Akira; Carsten J Kirschning; James F Zachary; John H Weis; Janis J Weis
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

6.  Lipoproteins of Borrelia burgdorferi and Treponema pallidum activate cachectin/tumor necrosis factor synthesis. Analysis using a CAT reporter construct.

Authors:  J D Radolf; M V Norgard; M E Brandt; R D Isaacs; P A Thompson; B Beutler
Journal:  J Immunol       Date:  1991-09-15       Impact factor: 5.422

7.  Differential expression of lymphocyte homing receptors by human memory/effector T cells in pulmonary versus cutaneous immune effector sites.

Authors:  L J Picker; R J Martin; A Trumble; L S Newman; P A Collins; P R Bergstresser; D Y Leung
Journal:  Eur J Immunol       Date:  1994-06       Impact factor: 5.532

Review 8.  Histopathology of clinical phases of human Lyme disease.

Authors:  P H Duray
Journal:  Rheum Dis Clin North Am       Date:  1989-11       Impact factor: 2.670

9.  Outer surface lipoproteins of Borrelia burgdorferi stimulate nitric oxide production by the cytokine-inducible pathway.

Authors:  Y Ma; K P Seiler; K F Tai; L Yang; M Woods; J J Weis
Journal:  Infect Immun       Date:  1994-09       Impact factor: 3.441

10.  Characterization and recruitment of plasmacytoid dendritic cells in synovial fluid and tissue of patients with chronic inflammatory arthritis.

Authors:  Roberto Lande; Elena Giacomini; Barbara Serafini; Barbara Rosicarelli; Gian Domenico Sebastiani; Giovanni Minisola; Umberto Tarantino; Valeria Riccieri; Guido Valesini; Eliana M Coccia
Journal:  J Immunol       Date:  2004-08-15       Impact factor: 5.422

View more
  21 in total

Review 1.  Syphilis: using modern approaches to understand an old disease.

Authors:  Emily L Ho; Sheila A Lukehart
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

2.  Phagocytosis of Borrelia burgdorferi and Treponema pallidum potentiates innate immune activation and induces gamma interferon production.

Authors:  Meagan W Moore; Adriana R Cruz; Carson J LaVake; Amanda L Marzo; Christian H Eggers; Juan C Salazar; Justin D Radolf
Journal:  Infect Immun       Date:  2007-01-12       Impact factor: 3.441

3.  Interleukin-10 alters effector functions of multiple genes induced by Borrelia burgdorferi in macrophages to regulate Lyme disease inflammation.

Authors:  Aarti Gautam; Saurabh Dixit; Mario T Philipp; Shree R Singh; Lisa A Morici; Deepak Kaushal; Vida A Dennis
Journal:  Infect Immun       Date:  2011-09-26       Impact factor: 3.441

4.  Structural and thermodynamic characterization of the interaction between two periplasmic Treponema pallidum lipoproteins that are components of a TPR-protein-associated TRAP transporter (TPAT).

Authors:  Chad A Brautigam; Ranjit K Deka; Peter Schuck; Diana R Tomchick; Michael V Norgard
Journal:  J Mol Biol       Date:  2012-04-11       Impact factor: 5.469

5.  Treponema pallidum elicits innate and adaptive cellular immune responses in skin and blood during secondary syphilis: a flow-cytometric analysis.

Authors:  Juan C Salazar; Adriana R Cruz; Constance D Pope; Liliana Valderrama; Rodolfo Trujillo; Nancy G Saravia; Justin D Radolf
Journal:  J Infect Dis       Date:  2007-02-05       Impact factor: 5.226

6.  Interaction of variable bacterial outer membrane lipoproteins with brain endothelium.

Authors:  Gaurav Gandhi; Diana Londoño; Christine R Whetstine; Nilay Sethi; Kwang S Kim; Wolfram R Zückert; Diego Cadavid
Journal:  PLoS One       Date:  2010-10-22       Impact factor: 3.240

7.  Serum lipoproteins attenuate macrophage activation and Toll-Like Receptor stimulation by bacterial lipoproteins.

Authors:  Sylvette Bas; Richard W James; Cem Gabay
Journal:  BMC Immunol       Date:  2010-09-16       Impact factor: 3.615

8.  Phagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytes.

Authors:  Adriana R Cruz; Meagan W Moore; Carson J La Vake; Christian H Eggers; Juan C Salazar; Justin D Radolf
Journal:  Infect Immun       Date:  2007-10-15       Impact factor: 3.441

9.  Activation of human monocytes by live Borrelia burgdorferi generates TLR2-dependent and -independent responses which include induction of IFN-beta.

Authors:  Juan C Salazar; Star Duhnam-Ems; Carson La Vake; Adriana R Cruz; Meagan W Moore; Melissa J Caimano; Leonor Velez-Climent; Jonathan Shupe; Winfried Krueger; Justin D Radolf
Journal:  PLoS Pathog       Date:  2009-05-22       Impact factor: 6.823

10.  Microglia are mediators of Borrelia burgdorferi-induced apoptosis in SH-SY5Y neuronal cells.

Authors:  Tereance A Myers; Deepak Kaushal; Mario T Philipp
Journal:  PLoS Pathog       Date:  2009-11-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.